(Q37810191)

23 August 2017

title

Assessing specificity for immunogenicity assays (English)

1 reference

23 August 2017

Steven J Swanson

1

1 reference

23 August 2017

Narendra Chirmule

series ordinal

2

1 reference

23 August 2017

publication date

1 June 2009

1 reference

23 August 2017

1 reference

23 August 2017

volume

1

1 reference

23 August 2017

issue

3

1 reference

23 August 2017

page(s)

611-617

1 reference

Recommendations on risk-based strategies for detection and characterization of antibodies against biotechnology products

23 August 2017

cites work

1 reference

Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin

21 January 2018

1 reference

Detection of neutralizing anti-therapeutic protein antibodies in serum or plasma samples containing high levels of the therapeutic protein

21 January 2018

1 reference

Validation of immunoassays used to assess immunogenicity to therapeutic monoclonal antibodies

21 January 2018

1 reference

Comparing ELISA and surface plasmon resonance for assessing clinical immunogenicity of panitumumab

21 January 2018

1 reference

Recommendations for the design, optimization, and qualification of cell-based assays used for the detection of neutralizing antibody responses elicited to biological therapeutics

21 January 2018

1 reference

Development of a "reverse capture" autoantibody microarray for studies of antigen-autoantibody profiling

21 January 2018

1 reference

Recommendations for the validation of immunoassays used for detection of host antibodies against biotechnology products

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.4155/BIO.09.41

1 reference

23 August 2017

1 reference